Table 2.
Change in lung function and heart rate on and off β blockers in the whole group of 38 participants
| Lung function or heart rate measurement | Change | p Value |
|---|---|---|
| FEV1 (L) | −0.10 (0.23) | 0.01 |
| FEV1 (% predicted) | −2.8 (5.9) | <0.01 |
| FVC (L) | −0.10 (0.28) | 0.98 |
| FVC (% predicted) | −0.8 (6.7) | 0.45 |
| FEV1/FVC | −0.01 (0.05) | 0.12 |
| RV/TLC (% pred.) | −0.8 (9) | 0.63 |
| Raw (kPa/s/L) | 0.15 (0.67) | 0.17 |
| sGaw (kPa/s) | 0 (0.03) | 0.73 |
| sRaw (kPa/s) | 0.91 (1.89) | <0.01 |
| Resting IC (L) | −0.01 (0.79) | 0.96 |
| Change in IC (L)—dynamic hyperinflation | −0.03 (0.29) | 0.5 |
| Heart rate (bpm) | −18 (19) | <0.01 |
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; IC, inspiratory capacity; Raw, airway resistance; RV, residual volume; sGaw, specific airway conductance; sRaw, specific airway resistance; TLC, total lung capacity.